Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2021-12-14 00:00:00 ET · period of report 2021-12-13 · accession 0001209191-21-069415 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-14 | 2021-12-13 | FATE | Valamehr Bahram | Chief R, D Off | S - Sale+OE | $47.66 | -25.0K | 172.6K | -13% | -$1.19M |
| D | 2021-12-14 | 2021-12-13 | FATE | Valamehr Bahram | Chief R, D Off | M - OptEx | $2.73 | +25.0K | 181.7K | +16% | +$68.2K |
| D | 2021-12-14 | 2021-12-13 | FATE | Valamehr Bahram | Chief R, D Off | M - OptEx | $0.00 | +25.0K | 61.2K | +69% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-13 | S | D | 2,100 | $45.68 | 179,598 | D | — | — | (F2) Represents the weighted average sale price of the shares sold from $45.18 to $46.17 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 6. |
| 2 | Common | Common Stock | 2021-12-13 | S | D | 7,718 | $48.75 | 158,298 | D | — | — | (F5) Represents the weighted average sale price of the shares sold from $48.21 to $49.20 per share. |
| 3 | Common | Common Stock | 2021-12-13 | S | D | 6,564 | $47.61 | 166,016 | D | — | — | (F4) Represents the weighted average sale price of the shares sold from $47.21 to $48.20 per share. |
| 4 | Common | Common Stock | 2021-12-13 | M | A | 25,000 | $2.73 | 181,698 | D | — | — | |
| 5 | Common | Common Stock | 2021-12-13 | S | D | 1,600 | $49.27 | 156,698 | D | — | — | (F6) Represents the weighted average sale price of the shares sold from $49.21 to $49.40 per share. |
| 6 | Common | Common Stock | 2021-12-13 | S | D | 7,018 | $46.72 | 172,580 | D | — | — | (F3) Represents the weighted average sale price of the shares sold from $46.20 to $47.17 per share. |
| 7 | Derivative | Stock Option (Right to Buy) | 2021-12-13 | M | A | 25,000 | $0.00 | 61,156 | D | $2.73 · — to 2027-01-04 | 25,000 Common Stock | (F7) This option is fully vested. |